OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2022-03-31-accounts

Contents
Chair's Report
Trusbx3' Report Ilncorporating Directors' and Strategic Reports) .... ...... .... ..... ..... .. . .6
About Us.
Public Benegt Statement.
How we raised our funding in 2021/22
How we used our resources in 2021/22
The people we help .10
Looking Back .12
What we achieved. .12
Service User Satisfaction Surveys .16
Countess ofChester Hospital Pharmacist Feedback.. .20
Performance
Data		 22
Main achievements .23
What we have not achieved .. .23
Looking forward ..
Good News Stories- some of our work.
Increasing Accessibility to Cheshire Hospices. .30
Working with LGBTI2I-community.
Working with People Experiencing Homelessness ..
Supporting
Carers..
Other patient stories
How we funded our achievements ..
Fundraising
and Trading .
Investments ...
Performance
Surplus ..
Our passionate
and dedicated		 people.
Patrons
gtVice Presidents		 36
The Hospice has a number of patrons and vice presidents who work on behalf ofthe organisation
within the local community ... 38
Senior Management
Team.
Subsidiary
Undertakings.
The Board and Subsidiary
Committee ..
Terms ofReference forour Committees. ..40
Chief Executive 45
Corporate Governance. . 45
RiskManagementand
Assurance. .
.		 ....... ... .. ..... ............... ..... ................. 45
Financial
Review .		 48
Management
ofreserves.		 48
Our people
Statement ofTrustees'
Responsibilities
forthe Financial Statements
and Corporate Governance		 51
Independent
Auditors'
Report Financial Statements.		 52
Balance Sheet for the year ended 31stMarch 2022. 58
Consolidated
Cash Fknv Statement forthe year ended 31stMarch 2022......... .. ...... .........		 59
Notes tothe Finandal Statements
for the year ended 31stMarch 2022 ...... ......... .. .. .. .		 60
We wanted tothank
Community
and Corporate Supporters. .
Charitable
Trusts and Funders ..		 .......... 84
Our Hospice Community
Fundraising
Groups .		 84
Patrons and celebrity supporters. .. ...... ...... ... .. ..... ..... ... ..... ......... . .....84

Patient Safety n effective and n effective and he structure ofthe nursing team was reviewed
efficient nursing m August 2020 following
consultation		 with
IPU
ructure on IPU aff resulting in additional hours which would
nable improved
line management
function,
dditional
senior support
during the evenings		 and
eekends.
The hours were fully staffed by
anuary 2022 and following
an induction
period
he new structure
was implemented
in February
022. Initial feedback was very positive, however
moving
into 2022/23 this system faced further
etbacks due to sustained
staff sickness and
urther vacancies.
It has however made the
stem more sustainable
with the additional
hours reducing the impact oflong- and short-
erm sickness and vacancies.
Patient Safety and Understanding of ork has commenced to establish
how long
linical Effectiveness referral patterns, wait ople are waiting for a bed at the hospice. It is
imes and reasons for recorded
how long the wait is and why there		 is a
same. ait. This work will be informing
further
bjectives for 22/23.
Clinical Effectiveness o increase the number tthe end of2022 the hospice had supported
fservice users with 29Sofpeople with a malignant
condition
and
non-malignant disease 189Swith a non-malignant
condition.
rom 159Sto 20 SEover
he year.
linical Effectiveness Increased
recording		 and Staff regularly
have conversations
regarding
reporting of Advance dvance Care Planning,
however the
re Planning recording
and reporting
mechanism
on our
Discussions. atient database was not as effective as it could
be. Following our outage and planned
move		 to
EMIS, initially anticipated
as being introduced		 in
pril 22, this objective became less prominent.
In t24 2021/22
58SSofpatients who died had their Preferred
Place ofCare recorded and 56SSachieved their
Preferred
Place of Death (the hos ice).
Clinical Effectiveness Utilisation ofOutcomes IPU and LWC staff use several aspects ofthe
sessment and OACC suite ofpatient outcomes - the Australian
omplexity Modified
Karnofski Performance
Scale (AKPS),
Collaborative (OACC) Phase ofillness (POI) and integrated
Palliative
data inform best utcome scale (IPOS).We have not yet been able
ractice and o develop an effective reporting
system,
demonstrate however the AKPS and POI is used as a guide for
ffectiveness ofservices patient dependency
on IPU and to assess the
o meet service user pproprlateness
ofreferral ofto the LWC. The
needs. IPOS tool is used by LWC Nursing staff as a guide
othe most appropriate
service such as Medical
utpatients,
Living Well Day, Complementary
herapy
and on IPU the information
gained
hrough
IPOS informs
nursing
and medical care
planning
and brings the patient voice to the
multi-disciplinary
team meetings.
Clinical Effectiveness Develop a mechanism ork delayed due to staffing issues. Move to
or early identification o 22/23 plan.
omplex discharges from
IPU and a process for
ptimising safe
ischarge. Reporting
nd reviews ofall
prolonged stays and
evelopment
of
valuation survey for
discharged patients.
linical Effectiveness Deliver a Single point of he aim ofthis work has been to have an easier
nd Patient Experience referral for all palliative referral route into palliative
care services. Rather
are referrals
within		 han the referrer identifying
which service is
est Cheshire. needed, be that Hospice, Community
or Hospital
utpatients,
the referrer
will make one single
referral. There will be a daily M-F meeting to
riage all referrals from the previous 24hrs. The
earn will identify which service
Ismost
ppropriate
to make the initial assessment
or
hether the person should be admitted
to the
hospice. There have been delays to the project
ork due to COVID-19 but in 21/22 the project
earn were awarded
funding
from Cheshire
and
irral Partnership
Trust for an admin. role which
ill coordinate the referrals, follow up with
referrers etc.This post will be appointed
to in
pring 22 with anticipated
implementation
in
2.
Patient Experience ofurther develop our Hospice
UK funding
came to an end in August
palliative and 2021,we were successful
in receiving a further
bereavement
support		 to rant from the CCG to continue supporting
our
hose experiencing homeless
work which commenced
in October
homelessness
within our		 021.In total the Palliative
Homelessness
Service
atchment and to begin Lead supported
13homeless
individuals
directly
o raise awareness of during 2021/22 and provided
low level indirect
hospice services to our upport through
advising professionals
for a
LGBTQ+ community. urther 17people. In addition, 19people
xperiencing
homelessness
accessed counselling
ervices provided
by hospice staff.
Following
a successful grant application
to
Hospice
UK an LGBTQ+ facilitator was appointed
o work across the 3 Cheshire
Hospices.
14
ommencing
October 2021.1nthe first 6 months
fher role she has worked with hospice staff on
policies and procedures
and prepared
and
delivered
training session, as well as establishing
hampions
in each hospice.
In 2022/223 she will
ork with HGS to apply for the Navajo Quality
Mark and help us to raise awareness ofhospice
ervices to the LGBTQ+ community.
Patient Experience odemonstrate the In Q4 —ofthose who responded
to the question
extent to which our freligion (140)the data shows that the majority
services are accessed by ofservice users (60SE) report they follow a
representatives from all Christian
religion,
28SE report they have no
four community, religion,
SSEreport themselves
as agnostic or
hrough
quarterly		 theist, 3.5SEreport their religion as other and 1SE
reporting ofprotected reported their religion as Hindu orJewish. Two
characteristics. people preferred
not to say.
ith regards to ethnicity ofthose who answered
(146)96SEdescribed themselves
English, Welsh,
cottish, Northern
Irish, Irish, or British, 2
respondents
were ofanother white background,
ith one each with an Asian or Asian British,
nother Asian background,
Black/
frican/Caribbean,
and another
Black
background.
ith regards to sexuality ofthose who answered
(142),973Edescribed themselves
as heterosexual
r straight, 2 people described themselves
as gay
r lesbian and 2 people described themselves
as
bi or bisexual.
Patient Experience New focus ofservice By Q2 some ofthe Living Well services were
elivery in LWS reinstated
face to face and all services
ollowing merger of recommenced
in Q3 with the option ofvirtual
Family Support and ervices still available for those who
Living Well Centre. preferred.
For patients
and carers, it has
enabled
a more seamless transition
between
different services in particular
counselling
ervices and the psychological
support
provided
by nursing
and complementary
therapy services.
Patient Experience Effective focussed Information
being collected, but because of
ervice user feedback. acancies within the quality team, focus is given
ofeedback where improvements
may be
required. These are reported to the Service User
roup and the Care Committee.
This will be an
ongoing objective for 22/23.
15

~ ~ 128 145 155
17 27 29
145 169 179
r. I 75 110 125
~. - I 107 94 88
~ ~ ~ 609Er 72% 69S6
8.98 13.4 12.3
a . ' a - ~
~ ~ ~ 21 27 8
6 1 9
13 17 13
~ ~ 11 24 48
~
~
~ ~ ~ r. 26 57 59
~ ~ r ~ N/A 53 40
~ ~ ~ ~ 96 190 215
~ ~ ~ ~ 26 69 65
a. ~ 53 190 223
~ ~
~ ~ ~ 400 431 553
~ ~ 82 98 108
~ ~ ~ 360 365 381
~ ~ 79 87 95

uality Area Priority How we identified How we identified How we identified How will we achieve it7 ow will we
it7 monitor7
afe Implementation o o date, the RADAR will be fully he development
a Quality Safety Hospice had a implemented
and live		 ancl
System to report paper system, by 1n October 2022. implementation
of
and analyse hich was then RADAR will be
Incidents, managed through 10096ofstaff will have monitored
through
omplaints, audit self-developed had the relevant llnical
nd policies and uality raining for the areas overnance
procedures. Management hey require. Monthly
as a
System. tandard
agenda.
By 30"November
022, each department e Quarterly
Care
ill be able to generate ommittee
will
relevant
reports for		 have oversight of
heir own areas. he development
and
Each department
will		 implementation.
be able to report on his will be
reas ofcompliance, reported tothe
nd areas ofnon- Board ofTrustees.
ompliance
will be
isible and transparent nce the system
or Senior Managers has been
nd the Trustee Board implemented,
a
o understand. report will be
provided to Clinical
Governance
on
number ofstaff
rained.
afe Introduce a new It was identified For EMISto be fully e development
Clinical System for hat the previous mplemented
and		 and
patient records ystem, Crosscare, unctional
by August.		 implementation
of
(EMIS), a system as not able to be EMIS will be
that is linked to compatible with By 30~ September 202 monitored
through
he local community II KPls can be reported linical
ommunity ervices, EMIS was on from EMIS overnance
services and GP chosen as a new chosen as a new 10096ofclinical staff 10096ofclinical staff Monthly as a
Records. clinical system as have been trained and s
tandard
agenda.
it was a system re fully conversant
used by GPs, Ith EMIS. e Quarterly
Care
District Nurses mmittee
will
and all community ave oversight of
rvices, allowing he development
r chnical records lid
(following strict implementation
Information his will be
Governance reported to the
Policy) can be Board ofTrustees.
linked.
KPls are able to be
reported
and are
accurate, packs can
be generated
for
he relevant
committee.
In Quarter 3—
relevant
audits are
undertaken
to
emonstrate
ompliance
with
he relevant
Hospice Policies
and Procedures.
afe o continue to udit remains a By Q1 Audit Annua I linical Audit
have an annual quality tool to Cycle will be completed Committee
udit cycle, to emonstrate nd signed offat the (Quarterly)
review care, compliance. udit Committee.
report on any Monthly
Clinical
improvements Number of audits that ovemance
hat are required. re undertaken. ommlttee
By 23"January 2022 Exception
he Quality Team will reporting to the
have bene restructured uarterly
Care
and will be fully omrnittee
staffed.
By end ofQuarter
4, all current audits
re on RADAR for
completion,
and
reports generated
from RADAR in
relation to gaps In
practice and the
ctions to mitigate
hese gaps.
Safe o undertake a hrough
evidence		 BySeptember 30the rom October 2022
uality vailable to the rst PDSA cycle will his will be
Improvement Hospice, and have been completed. reported
via the
Project for Quality his will seek views Monthly
Clinical
handoverand Improvement rom the staff. Plans overnance
incorporating ork In the NHS, or a Safety Huddle
will		 ommittee.
afety Huddles. afety Huddles have been developed
have Ith Safety Huddles Evidence of
emonstrated commencing
in Octobe		 ngagement
with
hat when they 2022. staff prior to the
ork well, they work for Safety
can help reduce During October 2022— Huddles
falls, safety issues he Safety Huddle
will		 ommencement.
re clear to staff have been reviewed,
n duty to help mendments/variatlon Evidence
that
maintain
safe		 III be made if required here is feedback
patient care. othe process, with a rom the staff in
econd PDSA cycle relation to their
completed
November		 xperience of
022. safety huddles and
hat this feedback
By March 31the Safety has been fully
Huddle
will be fully		 incorporated
integrated
in the		 within the PDSA
Inpatient
unit and		 cles where
integrated
as part of		 ppropriate.
handover.
afe o reduce errors It was identified o reduce Medicine onitored
through
ssociated with hrough
a deep		 rrors by 10%in he Monthly
he supply, delve
in Decembe		 2022/23 in comparison llnical
storage, 021that there with 2021/22. overnance
rescribing, ere areas that ommittee.
dministration, could be focussed o provide a Quality
nd disposal of on with Medicines Improvement
Bul(etin		 Monitored
through
medicines anagement in to all Inpatient
staff in		 he Quarterly
controlled drugs elation tothe October 2022 around Medicines
non-controlled afe delivery of safe management
of		 Management
rugs). edicines. medicines. Committee.
o undertake
a Quality		 Exception
Improvement
review of		 Reporting to Care
potential
contribution		 Committee
of medication Quarterly
incidents,
and for
uality Improvement
Plan developed
by 30
October.
linlcal Increased access odevelop Relevant
Policy,		 Numbers of
Effectiveness o intravenous hospice practice In Procedures
and		 patients receiving
herapies on the line with national Competency intravenous
inpatient unit. uidance
in order		 Framework
In place by		 interventions
o Improve October 2022. hrough Key
symptom Performance
management, II qualified
staff		 argets report to
improve patient rained
and achieved		 Monthly Clinical
xperience and competency
in the		 overnance and
prevent
hospital		 elivery ofIntravenous uarterly to Care
admissions. nterventions
by		 Committee.
December 2022.
Increased access of
atient receiving
Intravenous
Interventions,
measurement
in Qck
Patient Increased ooptimise use of o develop a strategy is will be
xperience provision and pace and breadth or the Living Well verseen by the
referrals into LWS fservices Centre with how this is Monthly Clinical
with improved vallable to to be achieved. This Governance and
patient patients
and		 trategy
will be		 uarterly Care
xperience. carers. developed
by March		 Committee.
2023.
Patient Increase Service o ensure that the Evidence that service Service User
Experience User Group ervice User user numbers
will		 I'oup.
membership by Group has good increase
by 109o.
10Yo. epresentation Quarterly Care
rom across all Committee.
hospice services
nd that
participation is
not too onerous
and remains
resh.
Patient Implement Implement and o develop e aim will be to have e aim will be to have Implementation
Experience valuate
new "I
ant Great Care"		 processes for
atient and		 "Iwant Great Care"
implemented
by 30"		 will be monitored
by
real time Patient ervice user October 2022. linical
atlsfaction eedback through Governance
urvey; publish the strategy of mmittee
he results on the improving digital Monthly.
Hospice website. platforms.
uarterly
Care
Committee.
Reports from the
patent/service use
eedback
will be
reported to Clinical
Governance
Monthly,
Service
User Group and by
Exception
Reporting to Care
Committee
uarterly.

Chief Executive Office Chief Executive Office Chief Executive Office Chief Executive Office Rhian W n Edwards
Director of Clinical Services (Caldicott Guardian) Liz Taylor
Director of Income Generation Caroline Siddall
Director of People and Development Julie Davles
Director of Finance &Operations An
eline		 Chlkuruwo (appointed 28~ March 2022)
Head of Finance David Haden (retired (retired 25" March 2022)
MedicalDirector/Palliative Care Consultant Dr Alison Coackley (a ointed 1"March 2022)
Responsible ainician Dr Lucy Cook (until 28~ Feb 2021)
Principle Registered Address Hospice ofthe Good Shepherd, Gordon Lane,
Backford, Chester CH2 4DG
Auditors Xeinadin Audit
Umlted
2 Hillards Court
Chester Business Park,
Chester, CH4 9QP
Solicitors Alllngton Hughes
2Vickers Lane
Chester
Ch1 1QX
Bankers NatWest PLC
Chester Commercial Office,
2"' Floor, 33Eastgate Street.
Chester CH1 1LG
Investment Advisors Investec Wealth & Investment Ltd
100Old Hall Street
Liverpool
L39AB

ed based on the ir score) as at t he date ofsigning:
Major Risks Controls
The Hospice continues to anticipate year-on- ~ Continued
monitoring
and scrutiny		 of
year deficits before legacy income. Current free all costs is in place as reserves remain
reserves are between 4 and 5 months of lower than target.
forecast expenditure
which is outside ofthe		 ~ Byagreement
with the CCG there		 is
recommended Charity Commission for sufficient
long-term
support to enable
resilience. The Boards target is 6months. The continued
operations.
We remain		 in
March 2022 Financial Statements have regular dialogue
with the CCG.
identified
a furth improvement		 in free reserves ~ Cost )mprove
ment
Plan has been
up to between 4 and Smonths at the end of replaced
by revised three-year
March 2021. forecasts.
~ Dally monitoring
ofcash and bank
balances.
~ Monthly
monitoring
ofincome and
expenses against budget and three-
year projections.
~ Monthly
monitoring
of balance sheet
and key solvency measures.
~ Regular monitoring
ofmovements		 in
freely available
Reserves,
~ Annual
budgeting
and update of three-		 Annual
budgeting
and update of three-
year projections.
Consultant Palliative Medicine/Medical In the absence of a Consultant
in
Director, (vacancy) which could lead to Palliative
Medicine, the Hospice has
potential impact on Cllnica I service(s), Strategic approved
an interim
medical model.		 A
Direction and managerial leadership ofthe Responsible
Clinician
(RC) will lead and
medical team and reputational damage support the Speciality Doctors (SDs)
externally as the Hospice Is not seen as a within the team.
forward-thinking organisation due to lack of Strategic Medical Objectives to focus
strategic activity relating to end-of-life care. on service improvements.
Move to SAS contracts for RC and SDs.
Jo(nt work with the Countess ofChester
(COC) NHS Trust and Cheshire
and
Wirral
NHS Partnership
(CWP) Trust		 to
agree consultant's
strategy for West
Cheshire.
Informal support
available from
Consultant(s)
in Palliative
Medicine at
COC and CWP NHS services Monday-
Friday 9-S pm.
Externa! clinical
supervision/arrangement
for RC.
Monthly doctor's business
meetings		 to
keep the medical team abreast of local
key clinical matters
and to highlight		 any
concerns or impact on services within
the Hospice.
Medical Director/Palliative
Care
Consultant
appointed
on 1"March
2022.
Financial constraints have led to the Work is prioritised.
deployment ofa lean nursing model especially Good communication.
at a senior level which could lead to staff burn- Careful planning
ofannual
leave/days
out or staff leaving as well as restricting/ off.
delaying professional development ofthe Train up senior staff to cover for
nursing'team. absence as need.
Reviewing the workload
ofthe Director
of Clinical Services work commenced.
Deployment
of Nurse
in Charge role.
New Interim
Quality Manager
has
clinical background
and governance
experience.
Commencement
ofnurse associate
pilot allowing junior staff to gain
further ex erience.

Forthe Tear ende d 31M arch 202 2
2022 2021
Note Unrestricted Restricted
Funds Fenrir Total Total
f 6 6
Income and endowments from:
Donations
and legacies		 1,012,796 114,129 1,126,925 1,057,985
Charitable
activities		 86,975 1,296,612 1,3834&7 1,610,864
Other trading activities 2,042,640 2,042NO 1,293,223
investments 11,146 11,146 9,89&
Other 39906 39906 142,240
Total Income and endowments 3,193,463 1,410,741 4,604,204 4,114,210
Expenditure
on:
Raising funds 7 (1,159,990) - (1,159,990) (892,687)
Charitable
acllvltles		 9 (1,592,655) (1383,817) (2r876,472) (2,591,430)
Other 10 (134,904
Total expenditure (2,752,645) (1,283,817) (4,036/62) (3,619,021)
Net gains
/ (losses)		 on
investments 11,497 22,497 107,48S
Net Income / (expandiuue) 452,315 126,924 579,239 602,677
Transfers between funds
Total funds brought forward 21 4,765,683 135,837 4,901,520 4,298,843
Total funds carried forward 21 5,217,998 262,761 5,480,759 4,901,520

2. Income from donations
and legacIes
a) Company end Group
Total Total
2022 2021
E
Oonatlons 548345 722,048
Legacies S78,680 335,937
Total 1,126,925 1,057,985

Company a nd Group
Total Total
2022 2021
E E
Contractual payments 1,308453 1,578,099
Sale ofgoods and services 625
Other 74,110 3?„76S
Total 1 83587 1,610864

a)Company Total Total
2022 2021
E E
Fundraislng Events 609,245 346,092
Total 609245 346092

b) Graup Total Total
2022 2021
E E
Fundralslng Events 609,245 346,092
touery 782595 748,195
Shops 650,800 198„t)36
Total 2,042,640 1,293223

g. Income g. Income from tnv as tments
a)Company Unrestricted Total
Funds 2022
Nate 5
US@IdUK IAvesurlQAts
hhddend Income 9433 9.533
short TeAlt GQ posit mterest 6
11+46		 1612
11,146
Gift Ald
HosPlca of the Good ShePherd 645,019 645P19
Promogans Umlted
5 IESE165
b}Group
Unrastdcted Total
Funds 2022
E E
Usmd UK lrlvastcAents
0lvldend Income 9533 9,533
SlccutTenn UepOdt Interest 1612
11,146		 1612
is.t46
tnvestm ants are held to provide sn overall return from both Income and capital growth.
s)Company Unrestdcted Total
Funds 2021
E
Usaad UK Investments
otvldand IACcurre
Shorl TQAIt Usposg illtomst F308 1 08
M08 2308
GIR Atd
Hospke oftha Good Shepherd 8 383,325 333,3'FS
Promotlons Umlted
384ABR 3846S3
b) Group
Unrastrhted Total
Funds 2021
5 E
Usted UKInvestments
0IVIESAIII A Cottle 8,590 S,590
Short Term Deposit Interost 1308
9898 9,898
Investments are held toprovide an overall return from both Income and capltst growth.

Total Tolst
2022 1021
E 5
ksr Retention scheme 0 66 55
other mcnma
wee		 Ena (2021:568535)ofwhich Eall was attributabfa torectrkled and Ena (10zlrEna)
wos attrlblsstss touurettrlctad hrmk.
b) Group Total Tol~I
2022 2021
5
lah Releiufon scheme 22A38 234204
covld ausnesv mrlas support
5 14 TA0
other Income wm 539ARRI(202k hlszgae) ofwhich Eaarnw was attributable lo veal ected
sml Ena
(202k E75,855)was attrexrudaa to unresltlded funds.
7. Expand(tureen mklug funck
4)CoruparlT Total
2022		 TOI4I
1021
E.
Msrd snaking end Event Costs 52T.626 249A92
Investment
msnsse mant		 nnls OA82 5534
Total
Expenditure on mhlng funds was 533170a(2021rEzslvnr6) ofwtvch En0p02k Ena) wm
slue utable toroltrkted funds snd E131708(2lkk 5253206)was attrlbuw hietoumeslncted
funds.
b)Group
Total Total
zco2 2021
E 5
shops and lone tv operadng cour 8k(Z8Z 639201
Marcsrulhlng and event costs 327,626 Zspv(92
Inv\Itrnellt
own age urwlt		 cons
Total

B. Results from Tr ading Activities ofSubsidiary
uoopko oftlNI Total Total
oooosoophus 2022 2021
plooxluoo umrul
E
Merchandising and Events 2,433,395 2,433395 947,131
Other Income 39906 39.906 75,855
Total income 1,473,301 1rP3,302 1,022,986
Total costs lndudlng taxadon (S28,282) (828,282) (639512)
Nat income for the year before Glit Aid 64')19 645,019 383,375
Gift Ald Payable to Hosp@a ofthe Good Shepherd (645,019) (645,019) (383,375)
Net income
Funds Srought forosard at1Aprg 2021
Funds Carried ponuard at 31March 2022 111 111
Total Assets 542012 542,012 518,?18
Total Llabgltlas (541,900) f542,900) {528,607)

Total
Unresulcted Restricted 2022
Salaries and Wages 991,294 1,229,915 2,221,209
Rentt 4,263 4,263
Rates and water 3,212 3,212
Ught and heat 5?g?2 5?A?2
Repairs and maintenance 117,028 5,919 122,9e?
Motor and travel expenses 4,754 519 5,273
lnsUfanca 17,410 17,410
Telephone 13.222 13,462
Medical suppBes 29,172 29,172
CUUrsln and edudlthm 11,876 8,073 19,949
Mlsceusneous 114,732 22.254 M6,986
laundry,
deanlng		 and food 37.717 3771?
Uepredauon 101,037 13,110 114,14?
postage, suulonmy and edverthlng 23,993AB 3,787 27,780
Audit fees 13,200 23300
legal and professional fees 40574 40,574
End ofUre padnmsiup 12,000 12MO
159?,S55 1,283,81? 2876?t?2
Tolal
Unlestlkted Restrkted 2021
Salaries end Wages
Rent		 tr482,140
2~		 608,545 2,090,6S5
2,571
Rates and water BSI28 8,818
Ught and heat 45,665 45,665
Repairs
and mslntansnc«		 79,048 S1,654
Motor and vevel expenses 2,?85 1JW8
Insumnce 15,724 15324
Tetephona 10,821 390 11311
Medlcat suppges 39,996 39ri96
Courses and education 6,215 510 6725
MlsceRaneous 31,448 252108 5?JISB
laundry,
clmudng		 and food 28,446 28,446
pepredatlan 98464 12,383 1ttt547
Postage, Stationery and adverthlng 24433 24,133
AudR fees 11,650 11,650
legal and professloml fees 39,?01 39702
End ofUfe Partnershi 15000 15/00
4 325 650,105 59L430

10. Other expenditure
a)Company Total Total
2022 2021
E
Staffcosts 0 68,385
Enll ofthe above costswere attributable to restricted funds and fnll {2021:Enf) were
attributable to unrestricted funds.
bjGroup Total Total
2022 2021
E f
Staffcasts 21,238 134r)04



Company oneeraup
2022
P
5 5
salaries and wages Actual 114,887 214,419 50,757
Roles and water Space 120 335 479
tight andheat Space 1,704 6,389 426 B„rlt9
Repairs and rnalntenance Actual 916 26rs87 916 28,319
Motor and tmac texpamm ActUOI 471 314 785
lrlsurance Space 649 1,S1S 130 2,595
Telephone Space 1,204 702 160 2,006
Mlscepsneous Actual 4,309 4309 8,618
ueluachtlnn Actual 1,701 25407 17,008
postage and stauonmy Aclwl I 2,690 1,449 4,139
Audit fees ActUOI 13,206 13300
legal and professional fees Acme! 40.574 40574
128.SS1 26L527 106.127 49th305
2011
St Sf
E 5 E
Salaries and Wages Actuaf 116,572 228.750 53UISG 399,018
Raise and water
light andheal		 Space
Space		 328
1,361		 910
sg03		 66
340		 2+24
6~
Rapahs and maintenance ACtltal 305 5.485 305 6,095
Mo'tot and travel experues
Insurance		 Achml
Space		 165
SBG		 110
1,640		 117 275
2~3
Tefep hone
Mlsceyanaous		 Space
Actual		 1,002
660		 585
660		 S4 1,671
1,320
papraclatlon Actual 1.647 14,824 16,4'll
postage and stauonery Actual S,S44 1,962 suuxt
AUdlt fees Actual 11,G50 11,650
legal and professional fees Actual 32,059 32,059
126.270 260.039 98 17 4S4626

12. Notlncome/(expenditure) forlheyaar
Net Income
/(expenditure)
Is		 stated alter charging /(credit lng): Total Total
2022 2021
4 f
Depredation
ol tangible fhed		 assets 130,102 129,043
Audit+'s renutneradon:
Audit ofthe anlttlat accounts 11,130 12750
Othor servkes 3,113 Q00

Total Tatel
2022 2021
E
2505,405 22I72,979
194,190 180,929
M»
Ta\st Total
2022 2011
5 5
4sr 51
14 29
27 21
115 106

a) Can psny a) Can psny Freehold Plarna Sbnurssb Motor
property madsnery fiNny vehkles Total
1 6 f 6 1
Cast
At 1/4/2021 3,785,950 1,2$,622 4,887J72
Additions 22,680 75,470 28322 126,472
Dhposalr/fugy tvrlt ten off
At 31/3/2022 3.808fi30 77,092 ZL322 5,014,044
Depredation
At 1/4/2021 SIIA236 $00.53$ 1,563,775
Charge for 'year Tb287 42,85$ 114,146
Egintnated oit dlspornt
At31/3/2022 73A523 943.398 677921
Net Seekvalue at 31/3/1022 3,074207 233694 28322 3,336,123
Net Book Vsiun at 31/3/2021 3,122714 201
3		 3,797
b)Group Freehold Plant tk Fixtures gi Motor
property lriilrmnery liilngs vemcles Totat
6 5 p. 6
Cost
At 1/4/2021 3,858,159 2,163,774 225,646 ~ 5,147479
Addldons 22,680 75,904 13362 28322 140,068
Dlsposals/fugy tvrkten ofI
At31/3/2022 3.8802I39 239 78 138/MS 28,322 5,287,647
Dupredsdon
At 2/4/20n 703,108 956/htt 78040 ~ 1.738,029
Charge for year 71,287 44YI03 14PI22 - 130402
Elknlnated an dlsposai
At 31/3/2022 774,395 1
284		 92452 1,868131
Nst Snort value at 31/3/2022 3,206/44 238394 sgasg 28 322 3r429516
Net SookValue at 31/3/2021 3155051 10S 93 47

16. Flvlld asset laluutrltefl\8 16. Flvlld asset laluutrltefl\8
Vflreslflctlld Total Total
Funds 2022 2021
5 8
Company and Group Rued Invmtments
At 1/4/202 | 517/)52 517,652 427A79
lam dlspasals et openlng market value )50,064) (50,064) (204333)
Add ecqldshtons Btcost l8,416 63,416 104,489
Imt pmsos)/gala an revaluation 9528 9 23 90317
At 31/3/2022
Tata! Told
2022 2021
1 6
Goods fofrassle
Total
Stockstndudad In um group balance sheet comp rise gaods hdd for resale.
18. Debtors
Co n Gfo
2021 2022 2021
E E
Amounts owed bygroup Imdsnsklnss 395,010 233375
ether pebtom 3,379 5 3376 5
VAT 23,736 27/743 23,736 27/f43
pralm/meme and Accrued Income 603,187 278A92 043,744 329374
Trade bebtom 3 3 229 3$42 3,229
1028418 53 4 074 3 8 339652

Fellttel yes sanded at M arch 1012
19. crcdltoun amounts f8Hfns dua within on8 ymr
Gron
2022 1021 2022 2021
6 6
Trade Creslers 77513 31/I73 83563 32,416
other Creditors 111,297 121564 tssjtao 222533
Sochl Iscullty Iuui osu!I' tllras 67536 46,660 745ss Sttsss
Accnmfs end deferred Hcome 271,815 242,351 397523 Sy2rsss
Amounts
owed tosrnup		 undmtsfdnsc
578360 441448 675541 576679
10.ccadaocu amounisfalsnsduaattarmore amounisfalsnsduaattarmore thsnons thsnons year
Curitp 8n Gr
2022 2021 2022 2021
6 E E
Other Creditors 734JI32 1,0S7591 734532 2587591
Gallic/
734
32		 1.087.991 734432 253t7591
21. Fund reconcSlstmn
~)Corepany
sshrnce st Esfanm 8t
01/04/2071 Income Expenditure Transfers lolsel 32/03/2022
E F.
Hmes Irlcted Fund s
Gsnenll itssarm 4,765570 2565,282 (2,924,359) 11597 5527589
4,763S70 256S 1 24359 11597 5527589
sshncaat Gse s/ aafsncu at
fd/04/2021 Incorlla Expeodlhrrs Trarnfsm toilet 3l/63/2022
E E E
Hosp@a ulcaoG Erdlsnd
Ccuhl hlnlsn5 1,026,092 (2.026,092)
lob Retsnlfun Scheme
otherRsftdctednmh 235,837 384,649 (257,725)
135,837 srt10,741 (2263527) 262,761

b)Group Ssisnce at Gains / Basta ca st
01/04/2021 mcome Expenditure Trmsfers tnssss 33/03/2022
E E E E
tfnrestrkted Funds
General Reserve 4,765,683 5293,463 (2,752/st 5)
4,765,688 3,193,463 {2,752.6rH) 11397 5,227 rmg
Balance at Gatns/ Bstsnceet
0I/04/2022 llrCOme Expenditure Trmlrflac tosses 32/03/2022
6 6 E 6
Restricted funds
Kospka UK4IKS England
Could funding 1,026,092 (1,026,092)
Iob Retention Scheme
Other Rmtrictad funds 335/337 384,649 (257,725)
13S 37 1,410,741 (1~.81 262,761

Hcatnce oftheeood shepherd
(Restate red
nmnber -
Holes tothe Ftnandal statements
Forthe year ended 31M arch 2022		 01s43427)
22. Anslyshnf net assets bstvmenfunds
8)Company Vnr8\trhted Rastdcted Toter
Funds Funlit 2022
5 8 5
TanSlble Fixed Asseh 3,279.652 56,471 MREvt23
lnvesiments 560432 560~2
Investmenls
ln substdWes		 2 2
Current Assets 154,920 2,S46,785
Currant VabEitles (528,360) (528360)
crac42ofsmore than one year (734,432) P34v452)
Total 5269,259 211,3 1 5/80,$50
UnrasWcted Rastrtctvd Total
Funds Funds 2022
E
T885lble Rued As&H 3,254,216 $9.581 3,323,797
Imesuncnta 517,652 517,652
Investments
in subsldladm		 2 2
CurrentAstels 2@23(239 66,256 2,589395
Current tfabtrrtlec (441,44S) (442r44S)
creultofs mom rhvn one year 1087.881 Soav
1
Total 4.765570 235837 4901307
b)droop Vafesidcted Rssldcted Total
Ftmds Furnls 2022
E 1 6
TanSlble Fixed Assets
tnvastrnents
Crufent Assets
Current llaIes		 3,363,045
566432
2,75S,465
(675,241)		 56/72
154,920		 3319,516
560532
2,910~
{675341)
CreEris nl Ore tfrart One year 34432 ?34
Total 5269,368 211392 5 80759
Vfuestdcted Rlnlficted Tote)
Funds I'amis 2821
5 E E
Tanslble FicedAssets 3,339,959 69,5$1 3,409550
investments 517,$52 517.652
Current Assets 2,572,732 66,256 22I38,98$
Currant VabIESss (57$,679) ~ (576,679)
Cfednofs mofa Iharl onoyear 2.0$7„ft91) - 087
1}
Total 4,765,684 18$,837 4rt02,521

Gmup
2Q22
Net income/(wrpendlture)
for year		 5793% 602,677
0 Ivies Iles received (QAH) (eAso)
Short Term Aeposh Interest (1,612) (spmg
Oeprectstton
snd bnpstrm ant oftnnggde		 Axed semis 130,102 129/nba
(norns)/ tosses oninvesrments tstrtuy) ftoyrt Oe)
(Profit}/ loss cmdhpomt oftsngitde Axmt assets 943
(Increase)/decrease
Instock		 (194) 1,142
(lncream}/dacnmmindebtom (334,747} 440/I77
Increase/(decressel
Incredhors		 (254,997) 176/55
comprise
Net cash Bowfrom opemdng setfvluos

The dtares In tubs ldlsry umlm losings are st
compssdee'		 ated stcast of5 2(2022.52)and the fohowl ng
Qass ofShare 2022 2021
Ihnpke olthe Rood Shepherd Promouons Umaed
Company
number: 03350371
Numbw of Shernu Nekl 2 2
te Shareholding Ordloxry 100)t 20075
Net Aeons 5 112 5112
operation of charity shop andslottery scheme.
Tolsiiutare
mlnlmumieme
p		 aymentssreas
fotl		 own
land altd
hugspngs Othec Total Total
2022 2022 2022 2021
Ytrdhtn One Year E65~ E
1rr51		 5
evsg		 1 6
75376
yytthtn Twoto Rue Years 166,060 1,472 sawn 95,750
Orer5yasrs
231,500 ~3423 ~234 3 271,126

28.Bnanclal fnslmments
~5em ~6 25
2022 1021 2022 2021
Bnandal assets at fair vafua thcou&h statement
ofRnandal acthrftles
Invesimenfs (Bole16) 560@2 517,652 560432 517,652
Investments In suhslryadas
prote 25)		 2 2
560534 517,654 560@2 517,652
ylnandal
emote that are		 debt imtruments
rumoured
a't		 mood fredcost
Anmuntsmved by&raup undertakfn8s(Note 18) 3952ft6 233375
shor
de&trna		 (Note 18) 3,379 5 3,376 5
VAT(Notes&) 23,736 17,043 23,736 27,043
Trade debtors(Natal)
csshatbaak
amt lnhaml		 3,600
~18		 3,229
IK7 51		 3542
~255192		 349
2 GG
1
2,243598 2322303 2,26fv447 2319,623
ylnancial Iiab&les that are debthntruments
measured
M		 smortfsed cost
Trade oedltom (Note 19) 771513 32,073 83,963 32/18
5ocfalsecurNyam(olher taxes(Note (9) 67,736 46586 74336 50,r)39
Olhercreditms (Notes tp f620) GG225 1215115 8532I32 1,210,224
950,978 1,2&7,088 1,012,151 2,293,202

2022
6
Total Reserves 5380,259 4,90h520
toss:
Unresutctad
Rxed Assets		 (3,363,045} (3~i(69}
Restdcted funds {262,762) (235rg37)
Freely available reserves U!54,953 2YS25,724